S&P 500   5,251.79 (+0.06%)
DOW   39,784.74 (+0.06%)
QQQ   444.90 (+0.02%)
AAPL   170.83 (-1.43%)
MSFT   420.79 (-0.15%)
META   487.78 (-1.23%)
GOOGL   150.37 (-0.33%)
AMZN   180.31 (+0.27%)
TSLA   176.56 (-1.82%)
NVDA   907.69 (+0.58%)
NIO   4.63 (-0.86%)
AMD   181.34 (+0.97%)
BABA   72.52 (+1.30%)
T   17.58 (+0.17%)
F   13.27 (+1.61%)
MU   118.57 (-0.48%)
CGC   9.55 (+0.00%)
GE   175.46 (-2.59%)
DIS   123.02 (+1.69%)
AMC   3.70 (-14.75%)
PFE   27.87 (+0.32%)
PYPL   66.80 (+0.35%)
XOM   115.64 (+0.58%)
S&P 500   5,251.79 (+0.06%)
DOW   39,784.74 (+0.06%)
QQQ   444.90 (+0.02%)
AAPL   170.83 (-1.43%)
MSFT   420.79 (-0.15%)
META   487.78 (-1.23%)
GOOGL   150.37 (-0.33%)
AMZN   180.31 (+0.27%)
TSLA   176.56 (-1.82%)
NVDA   907.69 (+0.58%)
NIO   4.63 (-0.86%)
AMD   181.34 (+0.97%)
BABA   72.52 (+1.30%)
T   17.58 (+0.17%)
F   13.27 (+1.61%)
MU   118.57 (-0.48%)
CGC   9.55 (+0.00%)
GE   175.46 (-2.59%)
DIS   123.02 (+1.69%)
AMC   3.70 (-14.75%)
PFE   27.87 (+0.32%)
PYPL   66.80 (+0.35%)
XOM   115.64 (+0.58%)
S&P 500   5,251.79 (+0.06%)
DOW   39,784.74 (+0.06%)
QQQ   444.90 (+0.02%)
AAPL   170.83 (-1.43%)
MSFT   420.79 (-0.15%)
META   487.78 (-1.23%)
GOOGL   150.37 (-0.33%)
AMZN   180.31 (+0.27%)
TSLA   176.56 (-1.82%)
NVDA   907.69 (+0.58%)
NIO   4.63 (-0.86%)
AMD   181.34 (+0.97%)
BABA   72.52 (+1.30%)
T   17.58 (+0.17%)
F   13.27 (+1.61%)
MU   118.57 (-0.48%)
CGC   9.55 (+0.00%)
GE   175.46 (-2.59%)
DIS   123.02 (+1.69%)
AMC   3.70 (-14.75%)
PFE   27.87 (+0.32%)
PYPL   66.80 (+0.35%)
XOM   115.64 (+0.58%)
S&P 500   5,251.79 (+0.06%)
DOW   39,784.74 (+0.06%)
QQQ   444.90 (+0.02%)
AAPL   170.83 (-1.43%)
MSFT   420.79 (-0.15%)
META   487.78 (-1.23%)
GOOGL   150.37 (-0.33%)
AMZN   180.31 (+0.27%)
TSLA   176.56 (-1.82%)
NVDA   907.69 (+0.58%)
NIO   4.63 (-0.86%)
AMD   181.34 (+0.97%)
BABA   72.52 (+1.30%)
T   17.58 (+0.17%)
F   13.27 (+1.61%)
MU   118.57 (-0.48%)
CGC   9.55 (+0.00%)
GE   175.46 (-2.59%)
DIS   123.02 (+1.69%)
AMC   3.70 (-14.75%)
PFE   27.87 (+0.32%)
PYPL   66.80 (+0.35%)
XOM   115.64 (+0.58%)
NASDAQ:SLGL

Sol-Gel Technologies (SLGL) Stock Price, News & Analysis

$0.98
0.00 (-0.50%)
(As of 11:13 AM ET)
Today's Range
$0.98
$1.00
50-Day Range
$0.95
$1.48
52-Week Range
$0.90
$4.39
Volume
3,194 shs
Average Volume
26,741 shs
Market Capitalization
$27.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

Sol-Gel Technologies MarketRank™ Stock Analysis

Analyst Rating
Strong Buy
3.50 Rating Score
Upside/​Downside
708.0% Upside
$8.00 Price Target
Short Interest
Healthy
0.14% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.96mentions of Sol-Gel Technologies in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.67) to ($0.41) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.84 out of 5 stars

Medical Sector

365th out of 939 stocks

Pharmaceutical Preparations Industry

165th out of 434 stocks

SLGL stock logo

About Sol-Gel Technologies Stock (NASDAQ:SLGL)

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; SGT-610, a rare disease for the treatment of Gorlin Syndrome which has completed Phase II clinical trials; and Erlotinib and Tapinarof to treat other rare skin indications. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

SLGL Stock Price History

SLGL Stock News Headlines

Sol Gel Technologies Ltd (SLGL)
SLGL May 2024 2.500 put
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Sol-Gel Technologies: Q4 Earnings Insights
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Expert Ratings for Sol-Gel Technologies
See More Headlines
Receive SLGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
3/28/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SLGL
Employees
36
Year Founded
1997

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$9.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+708.0%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

Net Income
$-27,240,000.00
Net Margins
-1,331.01%
Pretax Margin
-1,752.77%

Debt

Sales & Book Value

Annual Sales
$1.55 million
Book Value
$1.67 per share

Miscellaneous

Free Float
9,330,000
Market Cap
$27.58 million
Optionable
Optionable
Beta
1.34

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Alon Seri-Levy (Age 63)
    Co-Founder, CEO & Director
    Comp: $411k
  • Mr. Gilad Mamlok (Age 56)
    Chief Financial Officer
    Comp: $367k
  • Dr. Itzik Yosef (Age 48)
    Chief Operating Officer
    Comp: $236k
  • Mr. Moshe Arkin (Age 71)
    Executive Chairman of the Board
  • Prof. David Avnir
    Co-Founder
  • Ms. Tamar Fishman Jutkowitz (Age 48)
    VP & General Counsel
  • Dr. Karine Neimann (Age 53)
    VP of Projects & Planning and Chief Chemist

SLGL Stock Analysis - Frequently Asked Questions

Should I buy or sell Sol-Gel Technologies stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sol-Gel Technologies in the last year. There are currently 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" SLGL shares.
View SLGL analyst ratings
or view top-rated stocks.

What is Sol-Gel Technologies' stock price target for 2024?

2 Wall Street research analysts have issued 1 year target prices for Sol-Gel Technologies' stock. Their SLGL share price targets range from $7.00 to $9.00. On average, they predict the company's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 708.0% from the stock's current price.
View analysts price targets for SLGL
or view top-rated stocks among Wall Street analysts.

How have SLGL shares performed in 2024?

Sol-Gel Technologies' stock was trading at $1.1050 at the beginning of the year. Since then, SLGL shares have decreased by 10.4% and is now trading at $0.9901.
View the best growth stocks for 2024 here
.

Are investors shorting Sol-Gel Technologies?

Sol-Gel Technologies saw a drop in short interest in March. As of March 15th, there was short interest totaling 13,500 shares, a drop of 56.9% from the February 29th total of 31,300 shares. Based on an average trading volume of 28,200 shares, the short-interest ratio is presently 0.5 days. Currently, 0.1% of the company's stock are sold short.
View Sol-Gel Technologies' Short Interest
.

When is Sol-Gel Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our SLGL earnings forecast
.

How were Sol-Gel Technologies' earnings last quarter?

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) posted its quarterly earnings results on Thursday, November, 11th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.13. The business had revenue of $8.84 million for the quarter, compared to analysts' expectations of $9.53 million. Sol-Gel Technologies had a negative net margin of 1,331.01% and a negative trailing twelve-month return on equity of 61.52%.

What other stocks do shareholders of Sol-Gel Technologies own?
When did Sol-Gel Technologies IPO?

Sol-Gel Technologies (SLGL) raised $60 million in an IPO on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. ​Jefferies and BMO Capital Markets​ acted as the underwriters for the IPO and JMP Securities and Raymond James​ were co-managers.

Who are Sol-Gel Technologies' major shareholders?

Sol-Gel Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include Kingdon Capital Management L.L.C. (2.42%), Raymond James Financial Services Advisors Inc. (0.19%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Sol-Gel Technologies?

Shares of SLGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SLGL) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners